Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, Large B-Cell, Diffuse (DLBCL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01197560
What this trial is testing

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene 111
Early research (Phase 1)Study completedNCT04537715
What this trial is testing

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Who this might be right for
All MalignanciesAdvanced MalignanciesHematologic Malignancy+9 more
Epizyme, Inc. 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07771361
What this trial is testing

BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma and Multiple Myeloma

Who this might be right for
Non-Hodgkin Lymphoma Refractory/ RelapsedMultiple Myeloma RefractoryMultiple Myeloma in Relapse+5 more
Luminary Therapeutics 90
Large-scale testing (Phase 3)UnknownNCT03016000
What this trial is testing

Thalidomide Maintenance Treatment in DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Nanfang Hospital, Southern Medical University 226
Not applicableStudy completedNCT07007611
What this trial is testing

The Role of Surgical Resection AND Stereotactic Radiosurgery in Primary Central Nervous System -Diffuse Large B Cell Lymphoma

Who this might be right for
Primary Central Nervous System Diffusing Large Cell Lymphoma
jiahong Deng 76
Testing effectiveness (Phase 2)Study completedNCT00582725
What this trial is testing

R-CHOP + GM-CSF for Previously Untreated LCL in Elderly

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
University of Wisconsin, Madison 38
Post-approval studies (Phase 4)Study completedNCT00466258
What this trial is testing

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Who this might be right for
HIV InfectionsDiffuse Large B Cell Lymphoma
PETHEMA Foundation 50
Testing effectiveness (Phase 2)UnknownNCT05887726
What this trial is testing

Zanubrutinib Combined With R-CHOP Regimen in the Treatment of Newly Diagnosed DLBCL With High-risk Factors

Who this might be right for
Diffuse Large B Cell Lymphoma
Liaoning Cancer Hospital & Institute 30
Testing effectiveness (Phase 2)Ended earlyNCT04824794
What this trial is testing

GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies

Who this might be right for
Relapsed or Refractory Multiple Myeloma (RRMM)Diffuse Large B Cell Lymphoma (DLBCL)Acute Myeloid Leukemia (AML)
Genmab 130
Large-scale testing (Phase 3)Study completedNCT01321541
What this trial is testing

Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant

Who this might be right for
Diffuse Large B-cell Lymphomade Novo DLBCLDLBCL Transformed From Indolent Lymphoma+1 more
CTI BioPharma 312
Testing effectiveness (Phase 2)Looking for participantsNCT06918912
What this trial is testing

Study of Loncastuximab Tesirine in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) or High-Grade B-Cell Lymphoma (HGBCL) Following CAR-T Therapy Failure

Who this might be right for
Diffuse Large B-Cell LymphomaHigh-grade B-cell Lymphoma (HGBCL)B-Cell Lymphoma Treatment+1 more
Istituto Clinico Humanitas 50
Testing effectiveness (Phase 2)Looking for participantsNCT07189065
What this trial is testing

Rocbrutinib in Participants With Relapse or Refractory Non-GCB Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma (DLBCL)
Guangzhou Lupeng Pharmaceutical Company LTD. 150
Testing effectiveness (Phase 2)Looking for participantsNCT06649812
What this trial is testing

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Who this might be right for
High Grade B-Cell Lymphoma With MYC and BCL6 RearrangementsRecurrent Diffuse Large B-Cell LymphomaRecurrent Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type+12 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT02339805
What this trial is testing

Assessment of the Minimal Residual Disease in DLBCL From Cell-free Circulating DNA by NGS

Who this might be right for
Non Hodgkin Lymphoma
Centre Henri Becquerel 30
Testing effectiveness (Phase 2)WithdrawnNCT00829205
What this trial is testing

Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

Who this might be right for
Lymphoma
Cancer Research UK
Not applicableLooking for participantsNCT04300101
What this trial is testing

Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B Cell Lymphoma
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 300
Early research (Phase 1)Study completedNCT02658968
What this trial is testing

Study of Betalutin for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma (LYMRIT-37-05)

Who this might be right for
Relapsed, Diffuse Large B-cell LymphomaRefractory Diffuse Large B-Cell Lymphoma
Nordic Nanovector 18
Testing effectiveness (Phase 2)Study completedNCT02752204
What this trial is testing

An Evaluation AZD2014 Alone and in Combination With Rituximab in Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
University of Birmingham 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT04974216
What this trial is testing

Study of Tafasitamab and Lenalinomide Associated to Rituximab in Frontline Diffuse Large B-Cell Lymphoma Patients of 80 y/o or Older

Who this might be right for
DLBCL
The Lymphoma Academic Research Organisation 71
Testing effectiveness (Phase 2)Looking for participantsNCT06569485
What this trial is testing

Trilaciclib Combined With Chemotherapy in the Treatment of Diffuse Large B-Cell Lymphoma Patients

Who this might be right for
DLBCL
Sun Yat-sen University 38
Next Page
120